Long-term prognosis of Japanese patients with biologic-na?ve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

Rintaro Moroi; Katsuya Endo; Katsutoshi Yamamoto; Takeo Naito; Motoyuki Onodera; Masatake Kuroha; Yoshitake Kanazawa; Tomoya Kimura; Yoichi Kakuta; Atsushi Masamune; Yoshitaka Kinouchi; Tooru Shimosegawa

首页> 外文期刊>Intestinal research. >Long-term prognosis of Japanese patients with biologic-na?ve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

【24h】

Long-term prognosis of Japanese patients with biologic-na?ve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

机译：抗肿瘤坏死因子-α抗体治疗日本初生性克罗恩病患者的长期预后

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/Aims Few reports have described the long-term treatment outcomes of the anti-tumor necrosis factor-α antibody for Japanese Crohn’s disease (CD) patients. The aim of this study was to evaluate them and clarify the clinical factors that affect the long-term prognosis of the anti-tumor necrosis factor-α treatments.

机译：背景/目的很少有报道描述抗肿瘤坏死因子-α抗体对日本克罗恩病（CD）患者的长期治疗效果。这项研究的目的是评估它们并阐明影响抗肿瘤坏死因子-α治疗的长期预后的临床因素。

著录项

来源
《Intestinal research.》 |2019年第1期|共13页
作者
Rintaro Moroi; Katsuya Endo; Katsutoshi Yamamoto; Takeo Naito; Motoyuki Onodera; Masatake Kuroha; Yoshitake Kanazawa; Tomoya Kimura; Yoichi Kakuta; Atsushi Masamune; Yoshitaka Kinouchi; Tooru Shimosegawa;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类消化系及腹部疾病;
关键词
Crohn diseaseInfliximabAdalimumabLong-term prognosis;

机译：克罗恩病英夫利昔单抗阿达木单抗长期预后;

相似文献

外文文献
中文文献
专利

1. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. [J] . de-Rossi TM, Krauss N, Voll RE, Digestion . 2008,第4期

机译：用于抗肿瘤坏死因子-α抗体为难治性瘘管疾病的抗肿瘤坏死因子-α抗体患者治疗的患者的长期部分缓解。
2. Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea [J] . Lee Sang Mok, Han Eon Chul, Ryoo Seung-Bum, Annals of Coloproctology . 2015,第4期

机译：根据抗肿瘤坏死因子-α抗体的使用方法治疗胃肠道克罗恩病后的长期结果和再次手术的危险因素：在韩国单一研究所的35年经验
3. Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agents [J] . KestensC., vanOijenM.G.H., MulderC.L.J., Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2013,第7期

机译：对于以前未接受抗肿瘤坏死因子-α药物治疗的患者，阿达木单抗和英夫利昔单抗对克罗恩病同样有效
4. Production of nitric oxide, tumor necrosis factor-α and interleukin-6 by RAW264.7 macrophage cells treated with lactic acid bacteria isolated from kimchi [C] . Haeng Jeon Hur, Ki Won Lee, Hyong Joo Lee International Conference on Food Factors . 2004

机译：用乳酸菌分离的乳酸菌治疗的乳酸细胞生产一氧化氮，肿瘤坏死因子-α和白细胞介素-6
5. Yoga as an adjunctive therapy for Crohn's disease: A review of the effects of exercise and stress reduction on the quality of life and disease progression in Crohn's disease patients. [D] . Zuckerman, Julie. 2012

机译：瑜伽作为克罗恩氏病的辅助疗法：运动和减轻压力对克罗恩氏病患者生活质量和疾病进展的影响综述。
6. Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies [O] . Rintaro Moroi, Katsuya Endo, Katsutoshi Yamamoto, 2019

机译：抗肿瘤坏死因子-α抗体治疗日本初生性克罗恩病患者的长期预后
7. Similar outcomes for anti-tumor necrosis factor-α antibody and immunosuppressant following seton drainage in patients with Crohn's disease-related anal fistula [O] . Xutao Lin, Dejun Fan, Zerong Cai, 2016

机译：克罗恩病相关肛瘘患者塞塞引流后抗肿瘤坏死因子-α抗体和免疫抑制剂的类似结果

相关主题

Long-term prognosis of Japanese patients with biologic-na?ve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

摘要

著录项

相似文献

相关主题

期刊订阅